The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.

TOP CONTRIBUTORS

Tom McCarthy

CollegeStock...

Company Overview

INVO Bioscience, Inc. (OTCBB: IVOB) is a medical device company located in Beverly, MA that focuses on the development of treatment options for patients diagnosed with infertility. INOV Bioscience is dedicated to developing and providing cost effective reproductive healthcare therapies and solutions that focus on patient care and success. The company’s lead product, the INVOcell, is an innovative medical device used in infertility treatment that makes possible the vaginal incubation of eggs, sperm and early embryo development. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology.

Prior to 2008, INVO Bioscience was BioXcell. The company is said to have changed its name to better represent their dynamic and innovative approach to providing fertility treatment options for patients, and the company’s commitment to high levels of clinical excellence, treatment strategies and patient-centered care. Founder and chief scientist, Claude Ranoux, MD, has been in charge of the clinical affairs of the company since 2001. Dr. Ranoux is credited with inventing and developing the INVOcell and INVO procedure.

As listed on INVO Bisocience’s website, their mission statement is as follows: "INVO Bioscience offers novel solutions in assisted reproductive technologies, expanding geographic and affordable access to the global reproductive health care community. INVO Bioscience delivers outstanding quality products and services in compliance with worldwide regulatory requirements, providing value to our shareholders while recognizing the contributions of our employees."

References